Supramolecular Lipid Nanoparticles Based on Host–Guest Recognition: A New Generation Delivery System of mRNA Vaccines For Cancer Immunotherapy
Advanced Materials · 2024-06 · 36 (23)
DOI: 10.1002/adma.202311574 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 08.03.2024. Verfasst von Shaolong Qi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Bioorganic Phosphorus Chemistry & Chemical Biology, Department of Chemistry, Tsinghua University, Beijing, 100084, P. R. China. Hauptthemen laut MEDLINE: Nanoparticles, Cancer Vaccines, Dendritic Cells, Immunotherapy. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Beijing Municipal Science & Technology Commission, National Key R&D Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Dendritic cell (DC) maturation is a crucial process for antigen presentation and the initiation of T cell‐mediated immune responses. Toll‐like receptors play pivotal roles in stimulating DC maturation and promoting antigen presentation. Here, a novel message RNA (mRNA) cancer vaccine is reported that boosts antitumor efficacy by codelivering an mRNA encoding tumor antigen and a TLR7/8 agonist (R848) to DC using supramolecular lipid nanoparticles (SMLNP) as a delivery platform, in which a new ionizable lipid (N2‐3L) remarkably enhances the translation efficiency of mRNA and a β‐cyclodextrin (β‐CD)‐modified ionizable lipid (Lip‐CD) encapsulates R848. The incorporation of R848 adjuvant into the mRNA vaccine through noncovalent host–guest complexation significantly promotes DC maturation and antigen presentation after vaccination, thus resulting in superior antitumor efficacy in vivo. Moreover, the antitumor efficacy is further boosted synergized with immune checkpoint blockade by potentiating the anticancer capability of cytotoxic T lymphocytes infiltrated in tumor sites. This work indicates that SMLNP shows brilliant potential as next‐generation delivery system in the development of mRNA vaccines with high efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Bioorganic Phosphorus Chemistry & Chemical Biology, Department of Chemistry, Tsinghua University, Beijing, 100084, P. R. China.
- MOE Key Laboratory of Macromolecular Synthesis and Functionalization, Department of Polymer, Science and Engineering, Zhejiang University, Hangzhou, 310027, P. R. China.
- Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310009, China.
ORCID-Profile: Zhengwei Mao
Förderung
- Beijing Municipal Science & Technology Commission
- National Key R&D Program of China
- National Natural Science Foundation of China
- Tsinghua university Dushi Program
- Vanke Special Fund for Public Health and Health Discipline Development
- Tsinghua University
- Starry Night Science Fund of Zhejiang University Shanghai Institute for Advanced Study
- National Key Research and Development Program of China
Zitieren
APA
Qi, S., Zhang, X., Yu, X., Jin, L., Yang, K., Wang, Y., Feng, Y., Lei, J., Mao, Z., & Yu, G. (2024). Supramolecular Lipid Nanoparticles Based on Host–Guest Recognition: A New Generation Delivery System of mRNA Vaccines For Cancer Immunotherapy. Advanced Materials, 36(23). https://doi.org/10.1002/adma.202311574
Vancouver
Qi S, Zhang X, Yu X, Jin L, Yang K, Wang Y, et al. Supramolecular Lipid Nanoparticles Based on Host–Guest Recognition: A New Generation Delivery System of mRNA Vaccines For Cancer Immunotherapy. Advanced Materials. 2024;36(23). doi:10.1002/adma.202311574
BibTeX
@article{Qi2024,
author = {Qi, Shaolong and Zhang, Xueyan and Yu, Xinyang and Jin, Lulu and Yang, Kai and Wang, Yangfan and Feng, Yunxuan and Lei, Jiaqi and Mao, Zhengwei and Yu, Guocan},
title = {Supramolecular Lipid Nanoparticles Based on Host–Guest Recognition: A New Generation Delivery System of mRNA Vaccines For Cancer Immunotherapy},
journal = {Advanced Materials},
year = {2024},
volume = {36},
number = {23},
doi = {10.1002/adma.202311574}
}
EUVIMED